Form 10-Q NAVIDEA BIOPHARMACEUTICA For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Form 10-Q NAVIDEA BIOPHARMACEUTICA For: Mar 31

Navidea Biopharma (NAVB) Tops Q1 EPS by 1c

May 17, 2016 7:07 AM EDT

Navidea Biopharma (NYSE: NAVB) reported Q1 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.63 million.

The Company reiterates its 2016 total revenue estimate of $23 million to $25 million. Margins on Lymphoseek... More